Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

NCT02192333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 390

Last updated 2020-10-09

No results posted yet for this study

Summary

This randomized clinical trial studies survivorship care in reducing symptoms in young adult cancer survivors. Survivorship care programs that identify the needs of young adult cancer survivors and ways to support them through the years after treatment may help reduce symptoms, such as pain, fatigue, sleep disturbance, depression, and distress, in young adult cancer survivors.

Conditions

  • Breast Carcinoma
  • Cancer Survivor
  • Depression
  • Fatigue
  • Leukemia
  • Lymphoma
  • Malignant Bone Neoplasm
  • Malignant Digestive System Neoplasm
  • Malignant Female Reproductive System Neoplasm
  • Malignant Male Reproductive System Neoplasm
  • Pain
  • Sleep Disorder
  • Soft Tissue Sarcoma

Interventions

PROCEDURE

Management of Therapy Complications

Receive survivorship care

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Telephone-Based Intervention

Receive phone-based booster intervention

Sponsors & Collaborators

  • Livestrong Foundation

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • K. Scott Baker · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-03
Primary Completion
2017-10-07
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192333 on ClinicalTrials.gov